L-Dopa
L-DOPA, or levodopa, is an amino acid that the brain converts to dopamine. Combined with carbidopa, it is a medicine for Parkinson symptoms.
Also listed as Levodopa, L-3, 4-dihydroxyphenylalanine
What it is studied for
The strongest rated effects first. Bars show the size of the effect, the letter grades the evidence, and each rating lists the studies behind it.
What is L-DOPA?
L-DOPA, or levodopa, is converted to dopamine in the brain. As a medicine combined with carbidopa, it treats Parkinson symptoms. Carbidopa reduces breakdown before levodopa reaches the brain. 1
Why people take it
SuppCo community snapshot, 2026-09-28. Reasons for use are not evidence that it works.
Questions people ask
Is Mucuna the same as a levodopa combination tablet?
No. The tested supplements varied widely in levodopa and contained neither carbidopa nor benserazide. 2
Does the Parkinson trial support using it for everyday focus?
No. It assessed motor symptoms after single doses in people with advanced Parkinson disease, not attention in healthy people. 3
Is there an established safe supplement dose?
RIVM concluded that available information was insufficient to determine one for Mucuna preparations. 4
Did levodopa improve learning in healthy volunteers?
In the cited crossover experiment, reward learning worsened with levodopa/carbidopa compared with placebo. That result concerns the tested task. 5
Sources
- Levodopa and Carbidopa MedlinePlus
- Independent effects of age and levodopa on reversal learning in healthy volunteers Neurobiology of Aging, 2018